Future of the Smart Biopsy Devices Market: Trends, Innovations, and Key Forecasts Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Smart Biopsy Devices Market Size Growth Forecast: What to Expect by 2025?
The market size for intelligent biopsy tools has been exhibiting solid growth in the past few years. It's expected to leap from $2.85 billion in 2024 to $3.01 billion in 2025, showcasing a compound annual growth rate (CAGR) of 5.6%. This growth during the historical period is credited to the rise in cancer incidences, the desire for less invasive procedures, advancements in medicinal technology, and heightened diagnostic precision.

How Will the Smart Biopsy Devices Market Size Evolve and Grow by 2029?
In the coming years, the market size for smart biopsy devices is projected to experience significant growth. It's expected to reach $4.01 billion by 2029, with a compound annual growth rate (CAGR) of 7.4%. This speculated growth during the forecast period can be credited to several factors including the expansion of personalized medicine, advancements in imaging modalities, increased biopsy for biomarker analysis, entry of new market participants, and improved data connectivity. Top trends anticipated in the forecast period are robot-aided biopsies, AI-supported biopsy assistance, creation of cordless biopsy instruments, compact and handheld devices, as well as real-time guidance systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

What Drivers Are Propelling the Growth of Smart Biopsy Devices Market Forward?
The surge in cancer incidences is anticipated to bolster the expansion of the smart biopsy devices market in the future. Cancer encompasses a wide range of diseases that can originate in almost any organ or tissue when rogue cells multiply beyond control, breach their normal barriers, and either metastasize to other organs or infiltrate adjacent body parts. The increasing prevalence of cancer amplifies the demand for accurate and targeted tissue samples. This has catalyzed the development and enhancement of smart biopsy tools with superior molecular, imaging, and precision features to facilitate diagnosis and treatment planning. For instance, the World Health Organization, a Switzerland-based Intergovernmental organization, forecasted in January 2024 that there will be over 35 million new cancer cases by 2050, signifying a 77% increase compared to the projected 20 million cases and 9.7 million deaths in 2022. Hence, the upsurge in cancer incidences is fueling the expansion of the smart biopsy device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

What Trends Will Shape the Smart Biopsy Devices Market Through 2029 and Beyond?
Prominent players in the smart biopsy device industry are developing sophisticated products, including breast biopsy markers, to enhance the accuracy and efficiency of breast cancer detection. These markers are crafted to precisely identify the site of a tissue sample obtained in a biopsy, which is pivotal in guiding subsequent treatments and ensuring the right area is watched for potential cancerous growth. For example, Mammotome, a medical devices organization based in the U.S., introduced the Mammotome DualCore Dual Stage Core Biopsy System in August 2022. This innovatively invasive breast biopsy contraption employs a two-level process to deliver reliable, superior tissue samples. It's commonly coupled with ultrasound guidance for accurate, secure, and efficient breast cancer investigative diagnostics. This system can be incorporated with modern breast biopsy markers to present practitioners with a complete and cutting-edge solution for ultrasound-directed breast biopsies.

What Are the Key Segments in the Smart Biopsy Devices Market?
The smart biopsy devices market covered in this report is segmented -

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:
1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices
2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays
3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices
4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12271&type=smp

Who Are the Key Players Shaping the Smart Biopsy Devices Market's Competitive Landscape?
Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

What Geographic Markets Are Powering Growth in the Smart Biopsy Devices Market?
North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12271

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.